S1PR agonist - Boehringer Ingelheim
vibozilimod (SCD-044) - Sun Pharma
Zeposia (ozanimod) - BMS
Velsipity (etrasimod) - Pfizer
Mayzent (siponimod) - Novartis
https://s3.eu-central-1.amazonaws.com/m-anage.com.storage.eadv/abstracts_congress_2024/43190.pdf
 
Rajamannar Thennati* 1; Vinod Burade 1; Muthukumaran Natarajan 1; Rajan Kumar Pal 2; Vasu Sadashivam 3; Mudgal Kothekar 3; Siu-Long Yao 4; Thierry Duvauchelle 5; Jeanne-Marie Lecomte 6; Jean-Charles Schwartz 6
 
Aug 6, 2024
 
Prev Next